359 related articles for article (PubMed ID: 16959827)
1. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
Peralta CA; Shlipak MG; Fan D; Ordoñez J; Lash JP; Chertow GM; Go AS
J Am Soc Nephrol; 2006 Oct; 17(10):2892-9. PubMed ID: 16959827
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
3. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
6. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
[TBL] [Abstract][Full Text] [Related]
7. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
Onuigbo MA
Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
[TBL] [Abstract][Full Text] [Related]
8. Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States.
Frankenfield DL; Krishnan SM; Ashby VB; Shearon TH; Rocco MV; Saran R
Am J Kidney Dis; 2009 Apr; 53(4):647-57. PubMed ID: 19150157
[TBL] [Abstract][Full Text] [Related]
9. Familiality of cardiovascular mortality in end-stage renal disease patients.
Naiman N; Cheung AK; Goldfarb-Rumyantzev AS
Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871
[TBL] [Abstract][Full Text] [Related]
10. Body mass index and mortality in CKD.
Madero M; Sarnak MJ; Wang X; Sceppa CC; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
Am J Kidney Dis; 2007 Sep; 50(3):404-11. PubMed ID: 17720519
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
Lambert ND; Sacrinty MT; Ketch TR; Turner SJ; Santos RM; Daniel KR; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2009 Apr; 157(4):688-94. PubMed ID: 19332197
[TBL] [Abstract][Full Text] [Related]
13. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.
Thorp ML; Johnson ES; Yang X; Petrik AF; Platt R; Smith DH
Nephrology (Carlton); 2009 Apr; 14(2):240-6. PubMed ID: 19207866
[TBL] [Abstract][Full Text] [Related]
14. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
Postorino M; Marino C; Tripepi G; Zoccali C;
J Am Coll Cardiol; 2009 Apr; 53(15):1265-72. PubMed ID: 19358939
[TBL] [Abstract][Full Text] [Related]
15. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.
Taal MW; Sigrist MK; Fakis A; Fluck RJ; McIntyre CW
Nephron Clin Pract; 2007; 107(4):c177-81. PubMed ID: 17975325
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
18. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in CKD: what we know and what we need to know.
Clark LE; Khan I
Nephron Clin Pract; 2010; 114(2):c95-102. PubMed ID: 19887829
[TBL] [Abstract][Full Text] [Related]
20. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
